The Australian Medical Association Limited and state AMA entities comply with the Privacy Act 1988. Please refer to the AMA Privacy Policy to understand our commitment to you and information on how we store and protect your data.




Authority requirements for ongoing prescribing of Alprazolam from 1 February 2014

The AMA is providing information regarding implementation of the authority requirements for ongoing prescribing of Alprazolam from 1 February 2014.

Mr Colin Brown, Manager, Drug of Dependence Unit has provided this document outlining the reasons for the change and the process to be followed to obtain an authority (see PDF below)

General practitioners have been seeking clarification for patients on long term Alprazolam of what information from specialists the DDU would like to receive with the authority to prescribe Alprazolam.

The Drug of Dependence Unit has confirmed that a recent letter from a specialist supporting the ongoing prescribing should be sent with the application addressing any continuation in the context of the present evidence suggesting alternative medications and past treatment options for the patient.

This advice may mean that some patients will need to see the appropriate specialist prior to 1 February 2014, or their doctor will need to provide confirmation in the application that an appointment has been booked as soon as possible after that date with a specialist letter indicating interim support for continuance to be sent in with the authority application to the DDU.

Medical practitioners wanting to discuss specific patient issues should contact the Drug of Dependence Unit on 1300 652 584.

Uploaded on 16 December 2013